Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PYRAZINAMIDE
- Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
- Subclinical TB With Innovative Modified Short-course Regimens
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
- Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
- Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
- Intensified Short Course Regimen for TBM in Adults
- PanACEA - STEP2C -01
- Short-course Regimens for the Treatment of Pulmonary Tuberculosis
- The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis
- Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB
- Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)
- Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
- Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
- Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
- A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
- A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB
- Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
- Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
- A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2
- Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
- Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
- Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
- Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
- Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct
- Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
- Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
- A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant (DR-TB) Pulmonary TB Volunteers (PaSEM)
- Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
- BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)
- Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy
- Azacytidine During Anti-tuberculosis Therapy
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)
- The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
- Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
- Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis
- NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB
- Pilot Clinical Trial of PRS TB Regimen I - Phase II
- Pharmacokinetic Study of Linezolid for TB Meningitis
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis
- Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
- RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection
- Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis
- Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis
- Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
- Optimizing Treatment to Improve TBM Outcomes in Children
- Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
- The Protective Effect for Liver Organ in Patients With Anti-TB Drugs Using of Acetylcysteine (NAC)
- Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.
- Evaluating Newly Approved Drugs for Multidrug-resistant TB
- Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
- Treatment Shortening of MDR-TB Using Existing and New Drugs
- Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers
- A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
- Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia
- Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan
- The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
- PK Study of Anti-TB Drugs
- An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
- NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
- Shortening Treatment by Advancing Novel Drugs
- Assessing PA-824 for Tuberculosis (the APT Trial)
- Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation
- A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.
- Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents
- HRZE Fasted/Fed in Newly Diagnosed TB
- Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide
- Patients Response to Early Switch To Oral:Osteomyelitis Study
- Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection
- Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
- Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation
- Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)
- Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
- Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV
- Essentiality of INH in TB Therapy
- Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
- Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs
- Trial of High-Dose Rifampin in Patients With TB
- A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Fol
- Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment
- Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB
- Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)
- Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
- Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis
- Study of Daily Rifapentine for Pulmonary Tuberculosis
- Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
- Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
- Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
- Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
- Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage
- A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
- Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
- Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
- A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis
- Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis
- TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
- TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment
- Tuberculosis Treatment Shortening Trial
- Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
- Vitamin A Therapy for Tuberculosis
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
- Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis
- The Treatment of Tuberculosis in HIV-Infected Patients
- Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
- A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDR
- Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
- Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
Clinical trials list
click for details